BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22004172)

  • 1. Validity and reliability of the Malay-language translation of the Rome III Diagnostic Questionnaire for irritable bowel syndrome.
    Lee YY; Waid A; Tan HJ; Chua SB; Whitehead WE
    J Gastroenterol Hepatol; 2012 Apr; 27(4):746-50. PubMed ID: 22004172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rome III survey of irritable bowel syndrome among ethnic Malays.
    Lee YY; Waid A; Tan HJ; Chua AS; Whitehead WE
    World J Gastroenterol; 2012 Nov; 18(44):6475-80; discussion p. 6479. PubMed ID: 23197894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients.
    Gholamrezaei A; Zolfaghari B; Farajzadegan Z; Nemati K; Daghaghzadeh H; Tavakkoli H; Emami MH
    Acta Med Iran; 2011; 49(6):390-5. PubMed ID: 21874644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome: a population based study.
    Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Turkish version of the Rome III criteria for IBS is valid and reliable.
    Ozgürsoy Uran BN; Vardar R; Karadakovan A; Bor S
    Turk J Gastroenterol; 2014 Aug; 25(4):386-92. PubMed ID: 25254520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome.
    Whitehead WE; Palsson OS; Feld AD; Levy RL; VON Korff M; Turner MJ; Drossman DA
    Aliment Pharmacol Ther; 2006 Jul; 24(1):137-46. PubMed ID: 16803612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating the Research Diagnostic Criteria for Temporomandibular Disorders into Malay: evaluation of content and process.
    Khoo SP; Yap AU; Chan YH; Bulgiba AM
    J Orofac Pain; 2008; 22(2):131-8. PubMed ID: 18548842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of different diagnostic criteria for the irritable bowel syndrome among men and women.
    Hammer J; Talley NJ
    J Clin Gastroenterol; 2008 Feb; 42(2):160-6. PubMed ID: 18209586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
    Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician knowledge of Rome symptom criteria for irritable bowel syndrome is poor among non-gastroenterologists.
    Charapata C; Mertz H
    Neurogastroenterol Motil; 2006 Mar; 18(3):211-6. PubMed ID: 16487412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Red flag" evaluation yield in irritable bowel syndrome.
    Black TP; Manolakis CS; Di Palma JA
    J Gastrointestin Liver Dis; 2012 Jun; 21(2):153-6. PubMed ID: 22720303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
    Sperber AD; Shvartzman P; Friger M; Fich A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?
    Boyce PM; Koloski NA; Talley NJ
    Am J Gastroenterol; 2000 Nov; 95(11):3176-83. PubMed ID: 11095338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia.
    Kanazawa M; Nakajima S; Oshima T; Whitehead WE; Sperber AD; Palsson OS; Drossman DA; Miwa H; Fukudo S
    J Neurogastroenterol Motil; 2015 Oct; 21(4):537-44. PubMed ID: 26350938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
    Hillilä MT; Färkkilä MA
    Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.